Slough, United Kingdom

Fabien Claude Lecomte

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Fabien Claude Lecomte: Innovator in IL-17 Modulators

Introduction: Fabien Claude Lecomte, located in Slough, GB, is a distinguished inventor known for his significant contributions in the field of medicinal chemistry. With an impressive portfolio of 10 patents, Lecomte's innovations focus primarily on the development of IL-17 modulators that hold promise for treating various human ailments, particularly inflammatory and autoimmune disorders.

Latest Patents: Among his latest patents are two noteworthy inventions:

1. **Fused Imidazole Derivatives as IL-17 Modulators** - This patent involves a series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and their analogues. These compounds are recognized as potent modulators of human IL-17 activity, benefiting treatments for inflammatory and autoimmune disorders.

2. **Spirocyclic Indane Analogues as IL-17 Modulators** - Another patent, giving rise to a series of substituted spirocyclic indane derivatives, also shows efficacy as potent modulators of human IL-17 activity, aiding in the management of various human ailments related to inflammation and autoimmune responses.

Career Highlights: Fabien Claude Lecomte has worked with prominent companies such as UCB Biopharma Sprl and UCB Biopharma Srl. His expertise in developing innovative compounds has garnered recognition within the pharmaceutical community, especially for his work in understanding and enhancing IL-17 modulation.

Collaborations: Throughout his career, Lecomte has collaborated with notable professionals, including John Robert Porter and Boris Kroeplien. These partnerships highlight his commitment to advancing research and discovery in therapeutic applications.

Conclusion: Fabien Claude Lecomte stands out as a prolific inventor whose work in the field of IL-17 modulators reflects a deep understanding of medicinal chemistry. His patented innovations not only contribute to scientific progress but also offer potential solutions for treating serious health conditions, underscoring his significant impact in the realm of medical research and pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…